RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shandong Weigao Group Medical Polymer Co Stock

Shandong Weigao Group Medical Polymer Co Net Income 2024

Shandong Weigao Group Medical Polymer Co Net Income

2.21 B CNY

Ticker

1066.HK

ISIN

CNE100000171

WKN

A0M4WA

In 2024, Shandong Weigao Group Medical Polymer Co's profit amounted to 2.21 B CNY, a 10.26% increase from the 2 B CNY profit recorded in the previous year.

The Shandong Weigao Group Medical Polymer Co Net Income history

YEARNET INCOME (undefined CNY)
2026e2.66
2025e2.43
2024e2.21
20232
20222.76
20212.28
20202.09
20191.85
20181.47
20171.73
20161.11
20151.11
20141.08
20130.39
20121
20113.59
20100.8
20090.63
20080.48
20070.31
20060.17
20050.1
20040.07

Shandong Weigao Group Medical Polymer Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shandong Weigao Group Medical Polymer Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shandong Weigao Group Medical Polymer Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shandong Weigao Group Medical Polymer Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shandong Weigao Group Medical Polymer Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shandong Weigao Group Medical Polymer Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shandong Weigao Group Medical Polymer Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shandong Weigao Group Medical Polymer Co’s growth potential.

Shandong Weigao Group Medical Polymer Co Revenue, EBIT and net profit per share

DateShandong Weigao Group Medical Polymer Co RevenueShandong Weigao Group Medical Polymer Co EBITShandong Weigao Group Medical Polymer Co Net Income
2026e16.64 B undefined3.12 B undefined2.66 B undefined
2025e15.52 B undefined2.87 B undefined2.43 B undefined
2024e14.4 B undefined2.62 B undefined2.21 B undefined
202313.23 B undefined2.35 B undefined2 B undefined
202213.75 B undefined3.19 B undefined2.76 B undefined
202113.21 B undefined3.1 B undefined2.28 B undefined
202011.62 B undefined2.74 B undefined2.09 B undefined
201910.38 B undefined2.44 B undefined1.85 B undefined
20188.81 B undefined1.84 B undefined1.47 B undefined
20176.29 B undefined1.47 B undefined1.73 B undefined
20165.62 B undefined1.17 B undefined1.11 B undefined
20155.92 B undefined1.32 B undefined1.11 B undefined
20145.28 B undefined1.16 B undefined1.08 B undefined
20134.61 B undefined1.09 B undefined388 M undefined
20123.69 B undefined912.2 M undefined996.5 M undefined
20113.18 B undefined899.4 M undefined3.59 B undefined
20102.46 B undefined691.7 M undefined799.1 M undefined
20091.88 B undefined563.8 M undefined633.9 M undefined
20081.51 B undefined489.9 M undefined482.4 M undefined
20071.1 B undefined291 M undefined308.1 M undefined
2006786.9 M undefined178.4 M undefined170.9 M undefined
2005570 M undefined121.6 M undefined101.2 M undefined
2004407.8 M undefined81.7 M undefined65.9 M undefined

Shandong Weigao Group Medical Polymer Co stock margins

The Shandong Weigao Group Medical Polymer Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shandong Weigao Group Medical Polymer Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shandong Weigao Group Medical Polymer Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shandong Weigao Group Medical Polymer Co's sales revenue. A higher gross margin percentage indicates that the Shandong Weigao Group Medical Polymer Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shandong Weigao Group Medical Polymer Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shandong Weigao Group Medical Polymer Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shandong Weigao Group Medical Polymer Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shandong Weigao Group Medical Polymer Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shandong Weigao Group Medical Polymer Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shandong Weigao Group Medical Polymer Co Margin History

Shandong Weigao Group Medical Polymer Co Gross marginShandong Weigao Group Medical Polymer Co Profit marginShandong Weigao Group Medical Polymer Co EBIT marginShandong Weigao Group Medical Polymer Co Profit margin
2026e49.97 %18.75 %15.99 %
2025e49.97 %18.51 %15.68 %
2024e49.97 %18.19 %15.33 %
202349.97 %17.77 %15.13 %
202253.05 %23.18 %20.11 %
202155.61 %23.48 %17.23 %
202055.92 %23.6 %17.95 %
201962.73 %23.54 %17.82 %
201861.18 %20.87 %16.72 %
201763.45 %23.43 %27.47 %
201663.66 %20.86 %19.68 %
201559.4 %22.32 %18.8 %
201458.82 %21.93 %20.56 %
201359.11 %23.66 %8.41 %
201257.26 %24.73 %27.01 %
201155.34 %28.28 %112.76 %
201055.21 %28.09 %32.45 %
200953.3 %30.01 %33.75 %
200850.07 %32.35 %31.85 %
200745.69 %26.57 %28.13 %
200642.61 %22.67 %21.72 %
200541.11 %21.33 %17.75 %
200439.97 %20.03 %16.16 %

Shandong Weigao Group Medical Polymer Co Aktienanalyse

What does Shandong Weigao Group Medical Polymer Co do?

Shandong Weigao Group Medical Polymer Co Ltd is a globally operating company with headquarters in Weihai, China. It was founded in 1988 and has been listed on the Hong Kong Stock Exchange since 2004. The company specializes in the production of medical polymer products and offers a wide range of products for various applications. Its business model is that of an integrated platform for research, development, manufacturing, and marketing of medical devices. Their customers include hospitals, medical practices, and distributors worldwide. The company's portfolio includes products in the areas of infusion, blood transfusion, dialysis, surgery, anesthesia, first aid, and diagnostics. Both disposable and reusable products are available. With its offering, the company aims to contribute to improving the quality of healthcare and providing better outcomes for patients. Shandong Weigao Group Medical Polymer Co Ltd is divided into three divisions: Medical Devices, Medical Consumables, and Biology. The Medical Devices division manufactures devices for use in anesthesia, surgery, resuscitation, and diagnostics. The Medical Consumables division includes products such as syringes, catheters, infusion and transfusion devices, disposable gloves, and wound dressings. The Biology division specializes in the development, manufacturing, and marketing of biopharmaceutical products, such as insulin. The company's history is characterized by rapid expansion and continuous growth. The focus on R&D has played an important role in this. Through the use of advanced technologies, the company has acquired a multitude of patents in both China and other countries. The company places a strong emphasis on quality assurance and has implemented a comprehensive quality control system. In addition, it aims to minimize its environmental impact and therefore operates according to the latest environmental standards. In recent years, the company has established an international presence and opened subsidiaries in Europe and the USA. This demonstrates the company's desire to grow internationally and offer its products in more and more countries. In summary, Shandong Weigao Group Medical Polymer Co Ltd is an innovative company specializing in the production of medical polymer products and biopharmaceutical products. It offers a wide range of products and is committed to a comprehensive quality control system and sustainability. With its international presence, the company aims to continue growing and offer its products worldwide. Shandong Weigao Group Medical Polymer Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Shandong Weigao Group Medical Polymer Co's Profit Margins

The profit margins of Shandong Weigao Group Medical Polymer Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Shandong Weigao Group Medical Polymer Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Shandong Weigao Group Medical Polymer Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Shandong Weigao Group Medical Polymer Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Shandong Weigao Group Medical Polymer Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Shandong Weigao Group Medical Polymer Co stock

How much profit has Shandong Weigao Group Medical Polymer Co made this year?

Shandong Weigao Group Medical Polymer Co has made 2.21 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by 10.26% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Shandong Weigao Group Medical Polymer Co publish its earnings?

Shandong Weigao Group Medical Polymer Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Shandong Weigao Group Medical Polymer Co?

The profits of Shandong Weigao Group Medical Polymer Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Shandong Weigao Group Medical Polymer Co?

You can learn more about the earnings of Shandong Weigao Group Medical Polymer Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Shandong Weigao Group Medical Polymer Co pay?

Over the past 12 months, Shandong Weigao Group Medical Polymer Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 6.24 %. For the coming 12 months, Shandong Weigao Group Medical Polymer Co is expected to pay a dividend of 0.27 CNY.

What is the dividend yield of Shandong Weigao Group Medical Polymer Co?

The current dividend yield of Shandong Weigao Group Medical Polymer Co is 6.24 %.

When does Shandong Weigao Group Medical Polymer Co pay dividends?

Shandong Weigao Group Medical Polymer Co pays a quarterly dividend. This is distributed in the months of November, July, July, November.

How secure is the dividend of Shandong Weigao Group Medical Polymer Co?

Shandong Weigao Group Medical Polymer Co paid dividends every year for the past 23 years.

What is the dividend of Shandong Weigao Group Medical Polymer Co?

For the upcoming 12 months, dividends amounting to 0.27 CNY are expected. This corresponds to a dividend yield of 6.79 %.

In which sector is Shandong Weigao Group Medical Polymer Co located?

Shandong Weigao Group Medical Polymer Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shandong Weigao Group Medical Polymer Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shandong Weigao Group Medical Polymer Co from 11/22/2024 amounting to 0.092 CNY, you needed to have the stock in your portfolio before the ex-date on 10/18/2024.

When did Shandong Weigao Group Medical Polymer Co pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of Shandong Weigao Group Medical Polymer Co in the year 2023?

In the year 2023, Shandong Weigao Group Medical Polymer Co distributed 0.172 CNY as dividends.

In which currency does Shandong Weigao Group Medical Polymer Co pay out the dividend?

The dividends of Shandong Weigao Group Medical Polymer Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shandong Weigao Group Medical Polymer Co

Our stock analysis for Shandong Weigao Group Medical Polymer Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Weigao Group Medical Polymer Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.